25 results
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
agent of national reputation or the corporate trust department of a commercial bank.
3.4 Acceptance of Appointment by Successor. Every successor
SC 14D9/A
STSA
Satsuma Pharmaceuticals Inc
30 May 23
Tender offer solicitation (amended)
9:42pm
to choose Lazard as its financial advisor was based on Lazard’s reputation, familiarity with, and experience as a financial advisor to, the Company
SC 14D9
STSA
Satsuma Pharmaceuticals Inc
5 May 23
Tender offer solicitation
8:17am
Lazard’s reputation, familiarity with, and experience as a financial advisor to, the Company and other companies in the life sciences and biotechnology … to choose Lazard as its financial advisor was based on Lazard’s reputation, familiarity with, and experience as a financial advisor to, the Company
8-K
EX-2.1
STSA
Satsuma Pharmaceuticals Inc
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
and an independent financial advisor of nationally recognized reputation that (A) such Company Acquisition Proposal either constitutes a Company … consultation with outside counsel and an independent financial advisor of nationally recognized reputation, would reasonably be expected
8-K
EX-10.1
spuly
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
nfxqdk xj
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
10-K
kfl9 wc3pmuxdx
10 Mar 20
Annual report
4:20pm
10-Q
ecryrn
12 Nov 19
Quarterly report
4:31pm
424B4
1l8t9 gkyxjr
13 Sep 19
Prospectus supplement with pricing info
5:08pm